research
A Cancer Drug Assembles After Injection
WashU researchers delivered modular components separately and used click chemistry to join them at tumors in mice.
Summary
WashU researchers delivered modular components separately and used click chemistry to join them at tumors in mice.
The shape-shifting approach hit multiple targets and improved tumor control in animal experiments. It remains a preclinical drug-design strategy, not an available therapy.
Why it matters
WashU researchers delivered modular components separately and used click chemistry to join them at tumors in mice.
Limits and context
- It remains a preclinical drug-design strategy, not an available therapy.
Key claims
WashU researchers delivered modular components separately and used click chemistry to join them at tumors in mice.
Qualification: It remains a preclinical drug-design strategy, not an available therapy.
Evidence: source-2026-07-16-020
Sources
- Washington University via Newswise: Click-assembled cancer medicationWashington University in St. Louis via Newswise · official announcement
Corrections
No corrections have been recorded for this story.